Search

Search Constraints

You searched for: Author/Creator Eldehna, Wagdy M.

Search Results

1. 2-Arylquinolines as novel anticancer agents with dual EGFR/FAK kinase inhibitory activity: synthesis, biological evaluation, and molecular modelling insights. (1st January 2022)

2. 2-Arylquinolines as novel anticancer agents with dual EGFR/FAK kinase inhibitory activity: synthesis, biological evaluation, and molecular modelling insights. (31st December 2022)

5. Anti-cancer and immunomodulatory evaluation of new nicotinamide derivatives as potential VEGFR-2 inhibitors and apoptosis inducers: in vitro and in silico studies. (31st December 2022)

6. Antitumor properties of certain spirooxindoles towards hepatocellular carcinoma endowed with antioxidant activity. (1st January 2020)

7. Biological evaluation, docking studies, and in silico ADME prediction of some pyrimidine and pyridine derivatives as potential EGFRWT and EGFRT790M inhibitors. (1st January 2023)

8. Cancer stem cells CD133 inhibition and cytotoxicity of certain 3-phenylthiazolo[3, 2-a]benzimidazoles: design, direct synthesis, crystal study and in vitro biological evaluation. (1st January 2017)

9. ChemInform Abstract: 2‐((Benzimidazol‐2‐yl)thio)‐1‐arylethan‐1‐ones: Synthesis, Crystal Study and Cancer Stem Cells CD133 Targeting Potential. Issue 10 (February 2016)

10. Computational Prediction of the Potential Target of SARS‐CoV‐2 Inhibitor Plitidepsin via Molecular Docking, Dynamic Simulations and MM‐PBSA Calculations. Issue 2 (4th January 2022)